Both are healthcare tools. OpenEvidence has the higher Solthar Score, 84 to 80. Glass Health is free to start, with paid plans; OpenEvidence is free.
| Glass Health | OpenEvidence | |
|---|---|---|
| Category | Healthcare · Clinical | Healthcare · Research |
| Pricing | Freemium | Free |
| Free trial | Yes | Yes |
| Solthar Score | 80/100 | 84/100 |
Glass Health: what it does
Clinical decision support that drafts differentials from a patient summary. Glass Health is free to start, with paid plans, with a free trial. Solthar Score: 80/100.
Key features
- Differential diagnosis
- Evidence-linked plans
- Clinical note drafting
Strengths
- Built with clinicians
- Cites its sources
Trade-offs
- Support tool, never a decision maker
Read the full Glass Health page
OpenEvidence: what it does
Answers clinical questions with citations straight from the medical literature. OpenEvidence is free, with a free trial. Solthar Score: 84/100.
Key features
- Citation-backed answers
- Peer-reviewed sources
- Free for clinicians
Strengths
- Every claim is sourced
- Free for verified clinicians
Trade-offs
- Restricted to medical questions
Read the full OpenEvidence page
Which should you choose?
Choose Glass Health if built with clinicians matters most to you. Choose OpenEvidence if every claim is sourced matters more. If you only try one, OpenEvidence scores higher overall.